Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts

Takashi Kasukabe(Shimane University), Yoshio Honma(National Cancer Center Hospital East), Nobuo Kato(Kanazawa Medical University), Takeshi Sassa(Yamagata University), Junko Okabe‐Kado(Saitama Cancer Center)
Breast Cancer Research
November 9, 2005
Cited by 61


Related Papers